Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 221

    1.

    Association study of DTNBP1 with schizophrenia in a US sample.

    Zuo L, Luo X, Kranzler HR, Lu L, Rosenheck RA, Cramer J, van Kammen DP, Erdos J, Charney DS, Krystal J, Gelernter J.

    Psychiatr Genet. 2009 Dec;19(6):292-304.PMID: 19862852 [PubMed - in process]Related articles

    2.

    Population admixture modulates risk for alcohol dependence.

    Zuo L, Luo X, Listman JB, Kranzler HR, Wang S, Anton RF, Blumberg HP, Stein MB, Pearlson GD, Covault J, Charney DS, van Kammen DP, Price LH, Lappalainen J, Cramer J, Krystal JH, Gelernter J.

    Hum Genet. 2009 Jun;125(5-6):605-13. Epub 2009 Mar 22.PMID: 19306106 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Semantic memory in schizophrenia: association with cell membrane essential fatty acids.

    Condray R, Yao JK, Steinhauer SR, van Kammen DP, Reddy RD, Morrow LA.

    Schizophr Res. 2008 Nov;106(1):13-28. Epub 2008 Oct 16.PMID: 18929465 [PubMed - indexed for MEDLINE]Related articles

    4.

    Longitudinal progression of negative symptoms in schizophrenia: a new look at an old problem.

    Kelley ME, Haas GL, van Kammen DP.

    Schizophr Res. 2008 Oct;105(1-3):188-96. Epub 2008 Jul 11.PMID: 18619815 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Factor analytic support for social cognition as a separable cognitive domain in schizophrenia.

    Allen DN, Strauss GP, Donohue B, van Kammen DP.

    Schizophr Res. 2007 Jul;93(1-3):325-33. Epub 2007 May 10.PMID: 17498927 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effects of food on the pharmacokinetics of a formulated ACP-103 tablet in healthy volunteers.

    Vanover KE, Robbins-Weilert D, Wilbraham DG, Mant TG, van Kammen DP, Davis RE, Weiner DM.

    J Clin Pharmacol. 2007 Jul;47(7):915-9. Epub 2007 May 10. No abstract available. PMID: 17495279 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers.

    Vanover KE, Robbins-Weilert D, Wilbraham DG, Mant TG, van Kammen DP, Davis RE, Weiner DM.

    J Clin Pharmacol. 2007 Jun;47(6):704-14. Epub 2007 May 1.PMID: 17473118 [PubMed - indexed for MEDLINE]Related articles

    8.

    Differential patterns of premorbid academic and social deterioration in patients with schizophrenia.

    Allen DN, Frantom LV, Strauss GP, van Kammen DP.

    Schizophr Res. 2005 Jun 15;75(2-3):389-97. Epub 2005 Jan 5.PMID: 15885529 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effects of antipsychotic medication on factor and cluster structure of neurologic examination abnormalities in schizophrenia.

    Goldstein G, Sanders RD, Forman SD, Tarpey T, Gurklis JA, Van Kammen DP, Keshavan MS.

    Schizophr Res. 2005 Jun 1;75(1):55-64.PMID: 15820324 [PubMed - indexed for MEDLINE]Related articles

    10.

    Membrane phospholipids and cytokine interaction in schizophrenia.

    Yao JK, van Kammen DP.

    Int Rev Neurobiol. 2004;59:297-326. Review.PMID: 15006493 [PubMed - indexed for MEDLINE]Related articles

    11.

    CALCYON gene variation, schizophrenia, and cocaine dependence.

    Luo X, Kranzler H, Lappalainen J, Rosenheck R, Charney D, Zuo L, Erdos J, van Kammen DP, Gelernter J.

    Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):25-30.PMID: 14755439 [PubMed - indexed for MEDLINE]Related articles

    12.

    NOTCH4 gene haplotype is associated with schizophrenia in African Americans.

    Luo X, Klempan TA, Lappalainen J, Rosenheck RA, Charney DS, Erdos J, van Kammen DP, Kranzler HR, Kennedy JL, Gelernter J.

    Biol Psychiatry. 2004 Jan 15;55(2):112-7.PMID: 14732589 [PubMed - indexed for MEDLINE]Related articles

    13.

    Automatic activation of the semantic network in schizophrenia: evidence from event-related brain potentials.

    Condray R, Siegle GJ, Cohen JD, van Kammen DP, Steinhauer SR.

    Biol Psychiatry. 2003 Dec 1;54(11):1134-48.PMID: 14643080 [PubMed - indexed for MEDLINE]Related articles

    14.

    Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia.

    Yao JK, Sistilli CG, van Kammen DP.

    Prostaglandins Leukot Essent Fatty Acids. 2003 Dec;69(6):429-36.PMID: 14623497 [PubMed - indexed for MEDLINE]Related articles

    15.

    Elevated cerebrospinal fluid SNAP-25 in schizophrenia.

    Thompson PM, Kelley M, Yao J, Tsai G, van Kammen DP.

    Biol Psychiatry. 2003 Jun 15;53(12):1132-7.PMID: 12814864 [PubMed - indexed for MEDLINE]Related articles

    16.

    The language system in schizophrenia: effects of capacity and linguistic structure.

    Condray R, Steinhauer SR, van Kammen DP, Kasparek A.

    Schizophr Bull. 2002;28(3):475-90.PMID: 12645679 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

    Berlant J, van Kammen DP.

    J Clin Psychiatry. 2002 Jan;63(1):15-20.PMID: 11838620 [PubMed - indexed for MEDLINE]Related articles

    18.

    Characterization of human cleaved N-CAM and association with schizophrenia.

    Vawter MP, Usen N, Thatcher L, Ladenheim B, Zhang P, VanderPutten DM, Conant K, Herman MM, van Kammen DP, Sedvall G, Garver DL, Freed WJ.

    Exp Neurol. 2001 Nov;172(1):29-46.PMID: 11681838 [PubMed - indexed for MEDLINE]Related articles

    19.

    Neuroleptic effects on autonomic activity in schizophrenia: between-group and within-subject paradigms and comparisons with controls.

    Zahn TP, Pickar D, van Kammen DP.

    Schizophr Bull. 2001;27(3):503-15.PMID: 11596851 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

    Yao JK, Reddy RD, van Kammen DP.

    CNS Drugs. 2001;15(4):287-310. Review.PMID: 11463134 [PubMed - indexed for MEDLINE]Related articles

    21.

    Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia.

    Allen DN, Kelley ME, Miyatake RK, Gurklis JA Jr, van Kammen DP.

    Schizophr Bull. 2001;27(1):39-46.PMID: 11215548 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.

    Yao JK, Reddy R, van Kammen DP.

    Psychiatry Res. 2000 Dec 27;97(2-3):137-51.PMID: 11166086 [PubMed - indexed for MEDLINE]Related articles

    23.

    A 39-year followup of the Genain quadruplets.

    Mirsky AF, Bieliauskas LA, French LM, Van Kammen DP, Jönsson E, Sedvall G.

    Schizophr Bull. 2000;26(3):699-708.PMID: 10993407 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Factor structure of neurologic examination abnormalities in unmedicated schizophrenia.

    Sanders RD, Keshavan MS, Forman SD, Pieri JN, McLaughlin N, Allen DN, van Kammen DP, Goldstein G.

    Psychiatry Res. 2000 Sep 11;95(3):237-43.PMID: 10974362 [PubMed - indexed for MEDLINE]Related articles

    25.

    Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism.

    Allen DN, Goldstein G, Forman SD, Keshavan MS, van Kammen DP, Sanders RD.

    Neuropsychiatry Neuropsychol Behav Neurol. 2000 Jul;13(3):184-7.PMID: 10910089 [PubMed - indexed for MEDLINE]Related articles

    26.

    Neuroanatomic differences among cognitive and symptom subtypes of schizophrenia.

    Allen DN, Seaton BE, Goldstein G, Sanders RD, Gurklis JA Jr, Peters JL, van Kammen DP.

    J Nerv Ment Dis. 2000 Jun;188(6):381-4. No abstract available. PMID: 10890348 [PubMed - indexed for MEDLINE]Related articles

    27.

    Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes.

    Allen DN, Anastasiou A, Goldstein G, Gilbertson M, van Kammen DP.

    Psychiatry Res. 2000 Feb 14;93(1):33-9.PMID: 10699226 [PubMed - indexed for MEDLINE]Related articles

    28.

    Elevated interleukin-6 in schizophrenia

    van Kammen DP, McAllister-Sistilli CG, Kelley ME, Gurklis JA, Yao JK.

    Psychiatry Res. 1999 Oct 11;87(2-3):129-36.PMID: 10579546 [PubMed - as supplied by publisher]Related articles

    29.

    Relations between cognitive and symptom profile heterogeneity in schizophrenia.

    Seaton BE, Allen DN, Goldstein G, Kelley ME, van Kammen DP.

    J Nerv Ment Dis. 1999 Jul;187(7):414-9.PMID: 10426461 [PubMed - indexed for MEDLINE]Related articles

    30.

    Human plasma glutathione peroxidase and symptom severity in schizophrenia.

    Yao JK, Reddy RD, van Kammen DP.

    Biol Psychiatry. 1999 Jun 1;45(11):1512-5.PMID: 10356635 [PubMed - indexed for MEDLINE]Related articles

    31.

    Modulation of language processing in schizophrenia: effects of context and haloperidol on the event-related potential.

    Condray R, Steinhauer SR, Cohen JD, van Kammen DP, Kasparek A.

    Biol Psychiatry. 1999 May 15;45(10):1336-55.PMID: 10349041 [PubMed - indexed for MEDLINE]Related articles

    32.

    Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.

    Kelley ME, Yao JK, van Kammen DP.

    Neuropsychopharmacology. 1999 Jun;20(6):603-11.PMID: 10327429 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.

    Kelley ME, van Kammen DP, Allen DN.

    Am J Psychiatry. 1999 Mar;156(3):406-11.PMID: 10080556 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

    Yao JK, Reddy R, McElhinny LG, van Kammen DP.

    J Psychiatr Res. 1998 Nov-Dec;32(6):385-91.PMID: 9844955 [PubMed - indexed for MEDLINE]Related articles

    35.

    Construct validity of neuropsychological tests in schizophrenia.

    Allen DN, Aldarondo F, Goldstein G, Huegel SG, Gilbertson M, van Kammen DP.

    Assessment. 1998 Dec;5(4):365-74.PMID: 9835660 [PubMed - indexed for MEDLINE]Related articles

    36.

    Confirmatory factor analysis of the WAIS-R in patients with schizophrenia.

    Allen DN, Huegel SG, Seaton BE, Goldstein G, Gurklis JA Jr, van Kammen DP.

    Schizophr Res. 1998 Nov 9;34(1-2):87-94.PMID: 9824880 [PubMed - indexed for MEDLINE]Related articles

    37.

    Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia.

    Tsai G, van Kammen DP, Chen S, Kelley ME, Grier A, Coyle JT.

    Biol Psychiatry. 1998 Oct 15;44(8):667-74.PMID: 9798069 [PubMed - indexed for MEDLINE]Related articles

    38.

    Reduced level of plasma antioxidant uric acid in schizophrenia.

    Yao JK, Reddy R, van Kammen DP.

    Psychiatry Res. 1998 Jul 27;80(1):29-39.PMID: 9727961 [PubMed - indexed for MEDLINE]Related articles

    39.

    Individual differences in cognitive decline in schizophrenia.

    Goldstein G, Allen DN, van Kammen DP.

    Am J Psychiatry. 1998 Aug;155(8):1117-8.PMID: 9699706 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Reduced status of plasma total antioxidant capacity in schizophrenia.

    Yao JK, Reddy R, McElhinny LG, van Kammen DP.

    Schizophr Res. 1998 Jun 22;32(1):1-8.PMID: 9690328 [PubMed - indexed for MEDLINE]Related articles

    41.

    Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation.

    Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, Gelernter J.

    Hum Genet. 1998 May;102(5):533-40.PMID: 9654201 [PubMed - indexed for MEDLINE]Related articles

    42.

    GABA and brain abnormalities in schizophrenia.

    van Kammen DP, Petty F, Kelley ME, Kramer GL, Barry EJ, Yao JK, Gurklis JA, Peters JL.

    Psychiatry Res. 1998 Apr 10;82(1):25-35.PMID: 9645548 [PubMed - indexed for MEDLINE]Related articles

    43.

    Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia.

    van Kammen DP, Poltorak M, Kelley ME, Yao JK, Gurklis JA, Peters JL, Hemperly JJ, Wright RD, Freed WJ.

    Biol Psychiatry. 1998 May 1;43(9):680-6.PMID: 9583002 [PubMed - indexed for MEDLINE]Related articles

    44.

    Inter-rater reliability of the neurological examination in schizophrenia.

    Sanders RD, Forman SD, Pierri JN, Baker RW, Kelley ME, Van Kammen DP, Keshavan MS.

    Schizophr Res. 1998 Feb 9;29(3):287-92.PMID: 9516670 [PubMed - indexed for MEDLINE]Related articles

    45.

    No cytogenetical abnormalities in a set of schizophrenic quadruplets.

    Jönsson EG, Mirsky AF, Johannesson T, Wahlström J, Bieliauskas LA, van Kammen DP, Sedvall GC.

    Biol Psychiatry. 1997 Dec 15;42(12):1186-7. No abstract available. PMID: 9426891 [PubMed - indexed for MEDLINE]Related articles

    46.

    Ciliary neurotrophic factor null allele frequencies in schizophrenia, affective disorders, and Alzheimer's disease.

    Gelernter J, Van Dyck C, van Kammen DP, Malison R, Price LH, Cubells JF, Berman R, Charney DS, Heninger G.

    Am J Med Genet. 1997 Sep 19;74(5):497-500.PMID: 9342199 [PubMed - indexed for MEDLINE]Related articles

    47.

    Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia.

    Gilbertson MW, van Kammen DP.

    Biol Psychiatry. 1997 Oct 1;42(7):585-95.PMID: 9376455 [PubMed - indexed for MEDLINE]Related articles

    48.

    Utility of WAIS-R short forms in schizophrenia.

    Allen DN, Huegel SG, Gurklis JA Jr, Kelley ME, Barry EJ, van Kammen DP.

    Schizophr Res. 1997 Aug 29;26(2-3):163-72.PMID: 9323347 [PubMed - indexed for MEDLINE]Related articles

    49.

    Chronic haloperidol treatment does not affect structure of attention in schizophrenia.

    Allen DN, Gilbertson MW, van Kammen DP, Kelley ME, Gurklis JA Jr, Barry EJ.

    Schizophr Res. 1997 May 3;25(1):53-61.PMID: 9176927 [PubMed - indexed for MEDLINE]Related articles

    50.

    A simplified routine assay for urinary 3-methoxy-4-hydroxyphenylglycol.

    Yao JK, Zhu P, Wilds DJ, van Kammen DP.

    J Neural Transm. 1997;104(8-9):967-75.PMID: 9451728 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...